Transnasal Humidified Rapid Insufflation Ventilatory Exchange in children requiring emergent intubation (Kids THRIVE): a protocol for a randomised controlled trial.
Administration, Intranasal
Airway Management
Apnea
/ physiopathology
Carbon Dioxide
/ blood
Child
Emergency Service, Hospital
Humans
Humidifiers
Insufflation
/ methods
Intensive Care Units, Pediatric
Intubation, Intratracheal
/ adverse effects
Multicenter Studies as Topic
Oxygen Inhalation Therapy
/ methods
Randomized Controlled Trials as Topic
airway management
apnoeic oxygenation
intubation
nasal high-flow
paediatrics
transnasal humidified rapid insufflation ventilatory exchange
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
20 02 2019
20 02 2019
Historique:
entrez:
22
2
2019
pubmed:
23
2
2019
medline:
28
3
2020
Statut:
epublish
Résumé
Emergency intubation of children with abnormal respiratory or cardiac physiology is a high-risk procedure and associated with a high incidence of adverse events including hypoxemia. Successful emergency intubation is dependent on inter-related patient and operator factors. Preoxygenation has been used to maximise oxygen reserves in the patient and to prolong the safe apnoeic time during the intubation phase. Transnasal Humidified Rapid Insufflation Ventilatory Exchange (THRIVE) prolongs the safe apnoeic window for a safe intubation during elective intubation. We designed a clinical trial to test the hypothesis that THRIVE reduces the frequency of adverse and hypoxemic events during emergency intubation in children and to test the hypothesis that this treatment is cost-effective compared with standard care. The Kids THRIVE trial is a multicentre randomised controlled trial performed in participating emergency departments and paediatric intensive care units. 960 infants and children aged 0-16 years requiring emergency intubation for all reasons will be enrolled and allocated to THRIVE or control in a 1:1 allocation with stratification by site, age (<1, 1-7 and >7 years) and operator (junior and senior). Children allocated to THRIVE will receive weight appropriate transnasal flow rates with 100% oxygen, whereas children in the control arm will not receive any transnasal oxygen insufflation. The primary outcomes are defined as follows: (1) hypoxemic event during the intubation phase defined as SpO Ethics approval for the protocol and consent process has been obtained (HREC/16/QRCH/81). The trial has been actively recruiting since May 2017. The study findings will be submitted for publication in a peer-reviewed journal. ACTRN12617000147381.
Identifiants
pubmed: 30787094
pii: bmjopen-2018-025997
doi: 10.1136/bmjopen-2018-025997
pmc: PMC6398737
doi:
Substances chimiques
Carbon Dioxide
142M471B3J
Banques de données
ANZCTR
['ACTRN12617000147381']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e025997Investigateurs
Dr Philip Sargent
(DP)
Gold Coast University Hospitaldr Christa Bell
(GC)
Gold Coast University Hospital
(GC)
Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: SG, AS and SRD received travel support from Fisher and Paykel Healthcare.
Références
Can J Anaesth. 1994 Sep;41(9):771-4
pubmed: 7954992
Paediatr Anaesth. 2014 Dec;24(12):1204-11
pubmed: 25039321
BMC Pediatr. 2016 Apr 29;16:58
pubmed: 27130327
Lancet Respir Med. 2016 Jan;4(1):37-48
pubmed: 26705976
BMJ Open. 2015 Sep 18;5(9):e008522
pubmed: 26384724
Ann Emerg Med. 2012 Sep;60(3):251-9
pubmed: 22424653
Ann Emerg Med. 2009 Apr;53(4):426-435.e4
pubmed: 19026467
Pediatr Crit Care Med. 2017 Apr;18(4):310-318
pubmed: 28198754
Pediatr Crit Care Med. 2018 Jan;19(1):9-16
pubmed: 29135805
Pediatr Crit Care Med. 2012 Jan;13(1):e5-10
pubmed: 21057359
Emerg Med J. 2016 Jul;33(7):517-9
pubmed: 27330180
Paediatr Anaesth. 1996;6(4):251-63
pubmed: 8827740
Am J Emerg Med. 2017 Oct;35(10):1542-1546
pubmed: 28684195
J Crit Care. 2017 Oct;41:42-48
pubmed: 28477509
Br J Anaesth. 2017 Feb;118(2):232-238
pubmed: 28100527
Pediatrics. 2015 Nov;136(5):e1316-22
pubmed: 26438711
Anaesth Intensive Care. 2017 Jan;45(1):21-27
pubmed: 28072931
Heart Lung. 2017 Nov - Dec;46(6):452-457
pubmed: 28912057
BMJ Open. 2017 Nov 15;7(11):e018562
pubmed: 29146655
Am J Emerg Med. 2017 Aug;35(8):1177-1183
pubmed: 28623005